In a global Phase 3 gastrointestinal study, PiVOT managed a mid-trial rescue recruitment and still delivered on time, with full compliance and data integrity
Whittall-Garca L, Torres-Ruiz J, Zentella-Dehesa A, Tapia-Rodrguez M, Alcocer-Varela J, Mendez-Huerta N, et al
107 GLP-1s ability to mediate the incretin effect is its most studied and significant physiological effect due to the use of GLP-1 analogues (exenatide and liraglutide, lixisenatide, dulaglutide, albiglutide and semaglutide) in T2D treatment
While these are generally expected and temporary, being aware of them can help you manage the transition with confidence
You might be seeing the scale move in the right direction, but you may also notice new sensations in your body that you didnt anticipate